Adherence to aspirin in secondary prevention of ischemic stroke

Cerebrovascular Diseases

Volumn 21, Issue 5-6, 2006, Pages 353-356

  Lago, Aida ^a   Tembl, Jose Ignacio ^a   Pareja, Ana ^a   Ponz, Alejandro ^a   Ferrer, Jose Manuel ^a   Vallés, Juana ^a   Santos, Maria Teresa ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Aspirin; Cerebral ischemia; Secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID; THROMBOXANE A2; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CEREBROVASCULAR ACCIDENT; CHEMICAL ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; INTERVIEW; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT; BLOOD; BRAIN ISCHEMIA; EPIDEMIOLOGY; FOLLOW UP; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT;

ADULT; AGED; AMBULATORY CARE; ASPIRIN; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PLATELET AGGREGATION INHIBITORS; THROMBOXANE A2;

EID: 33748441257     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091542     Document Type: Article

References (14)

1. Diener HC: Antiplatelet drugs in secondary prevention of stroke: lessons from recent trials. Neurology 1997;49(Suppl 4):S75-S81.
2. Antithrombotic trialists' collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. BMJ 2002;324:71-86.
3. Kravitz RL, Hays RD, Donald C, DiMatteo R, Rogers WH, Ordway L, Greenfield S: Recall of recommendations and adherence to advice among patients with chronic medical conditions. Arch Intern Med 1993;153:1869-1878.
4. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Avorn J: Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med 1994;154:433-437.
5. Komiya T, Kudo M, Urabe T, Mizumo Y: Compliance with antiplatelet therapy in patients with ischemic cerebrovascular disease. Assessment by platelet aggregation testing. Stroke 1994;25:2337-2342.
6. Patrono C, Coller B, Dalen JE, FitzGerald GA, Fuster V, Gent M, Hirsh J, Roth G: Platelet-active drugs: the relationships among dose, effectiveness, and side effects. Chest 2001;119:39S-63S.
7. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 1993;24:35-41.
8. Uyttenboogaart MU, Stewart RE, Vroomen PCAJ, de Keyser J, Luijckx GJ: Optimizing cutoff scores for the Barthel index and the modified Rankin scale for defining outcome in acute stroke trials. Stroke 2005;36:1984-1987.
9. Vallés J, Santos MT, Aznar J, Osa A, Lago A, Cosín J, Sánchez E, Broekman J, Marcus AJ: Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality. The effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity. Circulation 1998;97:350-355.
10. Cotter G, Shemesh E, Zehavi M, Dinur I, Rudnick A, Milo O, Vered Z, Krakover R, Kaluski E, Kornberg A: Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? Am Heart J 2004;147:293-300.
11. Hamann GF, Weimar C, Glahn J, Busse O, Diener HC; German Stroke Data Bank: Adherence to secondary stroke prevention strategies - Results from the German Stroke Data Bank. Cerebrovasc Dis 2003;15:282-288.
12. Sappok T, Faulstich A, Stuckert E, Kruck H, Marx P, Koennecke HC: Compliance with secondary prevention of ischemic stroke. A prospective evaluation. Stroke 2001;32:1884-1889.
13. Simpson E, Beck C, Richard H, Eisenberg MJ, Pilote L: Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence. Am Heart J 2003;145:438-444.
14. Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum A, Flather MD, Granger CB, Erickson S, White K, Steg PG: Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med 2004;117:73-81.